---
title: Increased SIRT1 Concentration Following Four Years of Selenium and Q10 Intervention
  Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up—Sub-Study
  of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-HHV7W4SD" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Opstad, T. B., Alexander, J., Aaseth, J., Larsson, A., Seljeflot, I., &#38; Alehagen, U. (2023). Increased SIRT1 Concentration Following Four Years of Selenium and Q10 Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up—Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial. <i>Antioxidants</i>, <i>12</i>(3). <a href="https://doi.org/10.3390/antiox12030759">https://doi.org/10.3390/antiox12030759</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-HHV7W4SD" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=2141943" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/HHV7W4SD" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-HHV7W4SD" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-HHV7W4SD" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-HHV7W4SD" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://www.mdpi.com/2076-3921/12/3/759/pdf?version=1679964178" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://www.mdpi.com/2076-3921/12/3/759/pdf?version=1679964178" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-HHV7W4SD"></div>
</article>
<div id="csl-bib-meta-HHV7W4SD" class="csl-bib-meta">
  <article id="about-article-HHV7W4SD" class="about_pub-article">
    <h1>Om</h1>
    Opstad et al. gjennomførte ein studie for å undersøke om tilskot av selen og koenzym Q10 (SeQ10) kunne bidra til å redusere hjarterelaterte dødsfall. Dei følgde friske eldre vaksne i fire år, der ei gruppe fekk SeQ10 og ei anna gruppe fekk placebo. Dei fann at gruppa som tok SeQ10 hadde høgare nivå av eit protein kalla SIRT1, som er knytt til reduksjon av inflammasjon og aldring i blodårer. Etter ti år døydde færre personar i SeQ10-gruppa av hjarteproblem samanlikna med placebogruppa. Studien antyder at SeQ10 kan bidra til å beskytte hjartet ved å auke SIRT1-nivå og påverke visse genetiske markørar. Denne forskinga er viktig fordi den peikar på ein potensiell måte å forbetre hjartehelse og levetid.
  </article>
  <article id="keywords-article-HHV7W4SD" class="keywords-article">
    <h1>Emneord</h1>
    Selen, Koenzym Q10, SIRT1, Kardiovaskulær dødelegheit, MikroRNA, Antioksidantar, Antiinflammatorisk
  </article>
  <article id="abstract-article-HHV7W4SD" class="abstract-article">
    <h1>Samandrag</h1>
    Background: Selenium and coenzyme Q10 (SeQ10) possess antioxidant and anti-inflammatory 
properties, potentially mediated via Sirtuin1 (SIRT1). We aimed to investigate the influence of a 
SeQ10 intervention on SIRT1 concentration, with potential interactions with microRNAs. Methods: In 
this sub-study of a prospective double-blind placebo-controlled clinical trial, healthy subjects (mean 
age 76 years) were randomized to receive an active treatment (n = 165, combined 200 µg/day of Se 
and 200 mg/day of Q10) or a placebo (n = 161). SIRT1 concentration and microRNAs were measured 
with ELISA and PCR, respectively. Results: After four years, SIRT1 concentration was increased in the 
active treatment group, with mean (SD) ng/mL of 469 (436) vs. 252 (162), p < 0.001, and decreased 
in the placebo group, 190 (186) vs. 269 (172), p = 0.002, and the differences between the groups 
were significant (p = 0.006, adjusted). Those who suffered CV death during a 10-year follow-up 
(n = 25 and n = 52 in the active treatment and placebo groups, respectively) had significantly lower 
baseline SIRT1 concentrations compared to the survivors (p < 0.001). MiR-130a-3p was significantly 
downregulated during the intervention and correlated inversely with SIRT1 at baseline (r = −0.466, 
p = 0.007). Conclusion: The increased SIRT1 concentration after the SeQ10 intervention associated 
with reduced CV mortality, partly mediated via miR-1303a-3p, suggests that SIRT1 is an additional 
mediator of the intervention, preventing vascular ageing.
  </article>
  <article id="sdg-article-HHV7W4SD" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-HHV7W4SD" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=RX9SDGSP">2023</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=PNDWE2LR">April</a></li>
    </ul>
  </article>
</div>
